en · de · es · fr · pt
bench-notes.peptides6088.com › Info › Regulation And Detection Context — Beginner to Advanced

Regulation And Detection Context — Beginner to Advanced

By Editorial Desk · published 2026-03-04 · last reviewed 2026-04-19 · Info

This is a working overview of RP-HPLC, written for readers who want more than a one-paragraph summary but less than a textbook.

Reviewed 2026-04-19. Anything still debated is marked as such rather than presented as settled.

Regulation and Detection Context

Regulatory interest in AOD-9604 increased after high-profile anti-doping cases involving peptide products. In some cases, the substance was supplied under alternative names or in compounded preparations, complicating traceability. Sports tribunals and anti-doping panels have discussed whether the peptide was explicitly banned at the time of use, leading to clarifications by the World Anti-Doping Agency. For consumers and researchers, the legal status can vary by jurisdiction, and products marketed as research chemicals may lack independent quality verification.

AOD-9604 is listed as a prohibited substance in sport by the World Anti-Doping Agency. It falls under the peptide hormones, growth factors, related substances, and mimetics class on the prohibited list. Anti-doping organizations treat its presence in an athlete's sample as an adverse finding unless a therapeutic use exemption applies. The prohibition reflects concerns about performance enhancement in competitive settings and the difficulty of distinguishing exogenous peptide use from endogenous hormone fragments.

Identity And Research Background

AOD-9604 drew attention in the 1990s and 2000s as a potential anti-obesity agent. Early work explored both injectable and oral routes, which is unusual for a peptide of this size. Animal studies reported changes in fat metabolism without the growth-promoting or insulin-like effects associated with full-length growth hormone. Subsequent human trials produced mixed or modest results, and the compound did not obtain regulatory approval for weight management in major markets. It remains known mainly through research literature, sports anti-doping listings, and non-approved supplement advertising.

AOD-9604 is prohibited in sport by the World Anti-Doping Agency under the peptide hormone class. Its presence in a sample can be detected through mass spectrometry-based methods, although the exact assay depends on the laboratory. In research settings, material is often supplied as a lyophilized powder for reconstitution. Buyers and researchers should note that products labeled AOD-9604 may vary in purity and actual peptide content. Analytical certificates and independent testing are common ways to verify identity, but no global harmonized standard exists for all commercial lots.

Aod-9604 at a glance

PropertyValueNotes
Regulatory statusProhibited in sportListed by WADA under peptide hormones
WADA classS2Peptide hormones, growth factors, related substances, and mimetics
Approved therapeutic useNot establishedClinical research did not lead to broad marketing approval
Common detection methodLC-MS/MSLiquid chromatography-tandem mass spectrometry
Sample preparationExtraction and enrichmentImmunoaffinity or solid-phase extraction may be used

Research and Regulatory Status

Research interest in AOD-9604 often focuses on whether it can influence lipid metabolism without the growth-promoting or glucose-related effects of full-length hGH. This question remains unresolved, and findings depend on model, dose, and measurement method. Some reviews treat the peptide as a historical obesity candidate rather than an active therapeutic. Others cite it in discussions of peptide fragments, metabolic signaling, and performance-enhancing substances. Clear conclusions are limited by the small number of rigorous, independent human studies.

AOD-9604 has been investigated primarily as a potential treatment for obesity and related metabolic conditions. Early laboratory work examined its effects on fat cells, and later studies moved into animal models and human clinical trials. Some trials reportedly reached Phase II, but the program did not lead to an approved medicine. Published summaries often note that weight-loss results were modest or inconsistent. The full trial data are not all publicly available in detail.

Related pages on this site

Background and Development History

Clinical development of AOD9604 included trials in people with obesity, but the results did not lead to approval as a prescription medicine in major markets. Interest later shifted to research settings and to unapproved products marketed for body composition. Regulatory agencies have questioned whether the peptide qualifies as a dietary ingredient, and some have issued warnings about its presence in supplements. Long-term human safety data are limited, and questions about efficacy, dosing, and target populations remain unresolved.

AOD9604 is a synthetic peptide modeled on the C-terminal region of human growth hormone. It corresponds to a short sequence near the end of the 191-amino-acid hormone, often described as residues 176–191 or a related fragment. Researchers designed it to separate metabolic effects from the growth-promoting actions of full-length growth hormone. Early work in the 1990s explored it as a candidate for weight and lipid disorders. It is not a naturally circulating hormone fragment produced in large amounts.

Measurement and Storage Practices

Stability of AOD-9604 depends on storage conditions. Lyophilized powder is generally more stable than reconstituted solution. Recommended storage is typically at -20°C or lower, protected from light and moisture. Repeated freeze-thaw cycles can cause aggregation or degradation. In solution, the peptide may be susceptible to hydrolysis or oxidation, so aliquoting and cold storage are common practices. Researchers often add stabilizers such as mannitol or trehalose during lyophilization to improve shelf life.

Quality control for AOD-9604 involves verifying identity, purity, and concentration. Suppliers may provide a certificate of analysis listing HPLC purity and mass spectrometry data. Independent verification is advised because peptide products can vary in quality. Researchers should check for counterions, residual solvents, and microbial contamination. Proper documentation supports reproducibility and safety in laboratory studies. When sourcing, institutions often require third-party testing and detailed chain-of-custody records. These steps help ensure that experimental results are attributable to the peptide rather than impurities.

Analytical characterization of AOD-9604 typically employs reversed-phase high-performance liquid chromatography (RP-HPLC) to assess purity and identity. Mass spectrometry provides confirmation of molecular mass, while amino acid analysis can verify composition. These methods are standard for peptide research chemicals. Because the peptide lacks a distinct chromophore, detection often relies on ultraviolet absorbance at 214 nm or mass spectrometric response. Laboratories may also use capillary electrophoresis for separation. For example, size-exclusion chromatography can detect aggregates.

Research and Regulatory Context

Research on AOD-9604 also examines how the peptide is measured in biological samples. Analytical methods may include liquid chromatography coupled with mass spectrometry, immunoassays, or both. Detection can be challenging because the peptide is small and may be present at low concentrations. Published methods vary in sensitivity and specificity, so comparative interpretation requires attention to validation details. The presence of related hGH fragments can complicate identification in some matrices.

AOD-9604 has been investigated mainly in the context of body fat and metabolic endpoints. Some early animal and small human studies reported changes in fat mass or lipid markers, but findings were not uniform. Larger, well-controlled trials that would establish efficacy are lacking in the public literature. As a result, claims about weight loss or metabolic benefit remain investigational rather than established. The distinction between a research finding and a proven clinical outcome is central to discussing this peptide.

Supporting material

It resembles Grisons Buendnerfleisch, and first appears in works on gastronomy from about 1560. Bündnerfleisch – an air-dried meat that is produced in the canton of Graubünden, Switzerland, The main ingredient is beef, taken from the animal's upper thigh or shoulder, the fat and the sinews being removed. Before drying, the meat is treated with white wine and seasonings such as salt, onion and assorted herbs.

=== COVID-19 === The COVID-19 pandemic in 2020 produced a drastic tightening of border controls across the globe. Many countries and regions have imposed quarantines, entry bans, or other restrictions on citizens of, or recent travellers to, the most affected areas. Other countries and regions have imposed global restrictions that apply to all foreign countries and territories, or prevent their own citizens from travelling overseas. The imposition of border controls has curtailed the spread of the virus, but because they were first implemented after community spread was established in multiple countries in different regions of the world, they produced only a modest reduction in the total number of people infected These strict border controls economic harm to the tourism industry through lost income and social harm to people who were unable to travel for family matters or other reasons. When the travel bans are lifted, many people are expected to resume travelling. However, some travel, especially business travel, may decrease in the long term as lower-cost alternatives, such as teleconferencing and virtual events, are preferred. A possible long-term impact has been a decline of business travel and international conferencing, and the rise of their virtual, online equivalents. Concerns have been raised over the effectiveness of travel restrictions to contain the spread of COVID-19.

== Valence == Vaccines may be monovalent (also called univalent) or multivalent (also called polyvalent). A monovalent vaccine is designed to immunize against a single antigen or single microorganism. A multivalent or polyvalent vaccine is designed to immunize against two or more strains of the same microorganism, or against two or more microorganisms. The valency of a multivalent vaccine may be denoted with a Greek or Latin prefix (e.g., bivalent, trivalent, or tetravalent/quadrivalent). In certain cases, a monovalent vaccine may be preferable for rapidly developing a strong immune response.

=== Pet food === In the US, Turkestan cockroaches are sometimes kept to feed to pet reptiles and other insectivores, chosen partly because they can't climb smooth surfaces and don't burrow. Cockroaches have been replacing crickets, the most popular feeder insect for decades, due to the cricket's noise, odor, short lifespan, and expense. Turkestan cockroaches are a popular choice of species, and are readily available for sale over the Internet, which may hasten their spread to new habitats. Although reliable information on specific dietary requirements of insectivores is scant, Turkestan cockroaches provide a high-protein, low fat nutrition composition similar to crickets, more so than mealworms or superworm larvae provide. The gut contents of the cockroach, depending on its diet, may provide essential nutrients unavailable from a cockroach with an empty gut. In a study of commercially ordered specimens, small second instar nymphs (0.9–1.3 cm or 0.35–0.51 in) consisted of 21% dry matter, made of 76% crude protein and 14% crude fat, while medium third instar nymphs (1.3-1.9 cm) consisted of 28% dry matter, made of 53% crude protein and 27% crude fat. Mineral content is well represented except for a low calcium:phosphorus ratio typical in cockroaches, and calcium supplementation may be advisable. Vitamin A and E content was relatively low, and is generally significantly higher in free-ranging cockroaches.

Sources: en.wikipedia.org

Supporting material

== Conjugated zwitterions == Strongly polarized conjugated compounds (conjugated zwitterions) are typically very reactive, share diradical character, activate strong bonds and small molecules, and serve as transient intermediates in catalysis. Donor-acceptor entities are of vast use in photochemistry (photoinduced electron transfer), organic electronics, switching and sensing.

He told Tatler interviewer Charlotte Edwardes in 2016: "At prep school, I started a birdwatching club called the Tit Club. Every member was named after a member of the tit family: the Marsh Tit, the Blue Tit. I was the Great Tit". He once feared the story might reach the press: "I just know if that had got out when I was in active politics, I would never have recovered". Heseltine enjoyed angling in Brynmill Park and won a junior competition. He was educated at Broughton Hall in Eccleshall, Staffordshire, when it was briefly amalgamated with Brockhurst Preparatory school, Bromsgrove School, Worcestershire, and Shrewsbury School, Shropshire.

=== Gait === The hunched position that often results from complete spinal fusion can have an effect on a person's gait. Increased spinal kyphosis will lead to a forward and downward shift in center of mass (COM). This shift in COM has been shown to be compensated by increased knee flexion and ankle dorsiflexion. The gait of someone with ankylosing spondylitis often has a cautious pattern because they have decreased ability to absorb shock, and they cannot see the horizon.

Also important to Lagin has been ancient Native American rock art (petroglyphs) and European cave art "where pictures were placed and seen within nature and the natural world, not simply as representations or depictions but being part of, and kinship with, nature”. Lagin's picture-making includes nature and other photography, sand drawings, digital and physical paintings and drawings, and photographic nudes and self-portraits. His photography and art media span what he calls "the natural history of picture world"; his sand drawings using the earliest (oldest) picture-making medium (technology), and his digital photography, painting and electronic online picture presence the latest (newest) picture-making media (technologies). Most of Lagin's photography is of wilderness landscapes and seascapes, and 'intimate landscapes' of rocks and sea stones, plants, grasses, flowers, meadows, trees and forests, streams, water, sand, clouds and skies. His photos, drawings, and paintings are mostly from/of nearby wild places and home (Marin County, California). Besides many single photographs and small sets, he has created two large continuing nature photography collections, both with philosophical and spiritual themes: metaphysics (nature photos and sand drawings), and seeings (intimate nature).

== Mechanism of action == Malacidins appear to take on their active conformation after they bind to calcium; the calcium-bound molecule then appears to bind to lipid II, a bacterial cell wall precursor molecule, leading to destruction of the cell wall and death of the bacteria. Therefore, they would be a new member of the class of calcium-dependent antibiotics. The discovery of malacidins supported the view that the calcium-dependent antibiotics are a larger class than previously thought.

Sources: en.wikipedia.org

Supporting material

== Abundance == Reversible phosphorylation of proteins is abundant in both prokaryotic and even more so in eukaryotic organisms. For instance, in bacteria 5–10% of all proteins are thought to be phosphorylated. By contrast, it is estimated that one third of all human proteins is phosphorylated at any point in time, with 230,000, 156,000, and 40,000 unique phosphorylation sites existing in human, mouse, and yeast, respectively. In yeast, about 120 kinases (out of ~6,000 proteins total) cause 8,814 known regulated phosphorylation events, generating about 3,600 phosphoproteins (about 60% of all yeast proteins). Hence, phosphorylation is a universal regulatory mechanism that affects a large portion of proteins. Even if a protein is not phosphorylated itself, its interactions with other proteins may be regulated by phosphorylation of these interacting proteins.

He was succeeded by Kazuo Ito as president. In April 2002, Ajinomoto reorganized itself into food, amino acid, and medicine divisions, and owned subsidiaries for frozen foods, fats, and oils. In February 2003, Ajinomoto and Unilever completed a joint venture agreement in six countries and regions of Asia. Because of this, Ajinomoto launched the brand VONO to replace its use of the Knorr brand, and in the process established its own brand identity. In July 2003, Ajinomoto bought the French company Orsan from the UK-based Tate and Lyle Group, renaming Orsan to AJI-NO-MOTO Foods, Europe. In November 2005, AJI-NO-MOTO Pharmaceuticals USA, Inc. was liquidated, and its assets and functions were merged into AJI-NO-MOTO Pharmaceuticals, Europe. In January 2006, Ajinomoto bought the cooking sauce and condiments manufacturer Amoy Food from the French dairy company Groupe Danone. In 2009, the company released "Ajinomoto" to commemorate the 100th anniversary of its foundation.

Merck Millipore was the brand used by Merck Group's (not US-based Merck & Co.) global life science business until 2015 when the company re-branded. It was formed when Merck acquired the Millipore Corporation in 2010. Merck is a supplier to the life science industry. The Millipore Corporation was founded in 1954, and listed among the S&P 500 since the early 1990s, as an international biosciences company which makes micrometer pore-size filters and tests. In 2015, Merck acquired Sigma-Aldrich and merged it with Merck Millipore. In the United States and Canada, the life science business is now known as MilliporeSigma.

==== Middle East ==== In Arab countries, dill seed, called ain jaradeh (grasshopper's eye), is used as a spice in cold dishes such as fattoush, and pickles. In Arab countries of the Persian Gulf, dill is called 'shibint' and is used mostly in fish dishes. In Egypt, dillweed is commonly used to flavour cabbage dishes, including mahshi koronb (stuffed cabbage leaves).

Type B: onset at age 20 or older and duration of less than 10 years. Type C: onset at age 10–19 or duration of 10–19 years. Type D: onset before age 10 or duration greater than 20 years. Type E: overt diabetes mellitus with calcified pelvic vessels. Type F: diabetic nephropathy. Type R: proliferative retinopathy. Type RF: retinopathy and nephropathy. Type H: ischemic heart disease. Type T: prior kidney transplant. An early age of onset or long-standing disease comes with greater risks, hence the first three subtypes. Two other sets of criteria are available to diagnose gestational diabetes, both based on blood-sugar levels. Criteria for diagnosis of gestational diabetes, using the 100-gram Glucose Tolerance Test, according to Carpenter and Coustan:

Sources: en.wikipedia.org

Frequently asked questions

Is AOD-9604 banned in sport?

Yes, the World Anti-Doping Agency classifies AOD-9604 as a prohibited peptide hormone and related substance. Its use by athletes is banned under the relevant anti-doping code.

How is AOD-9604 detected?

Confirmatory detection typically uses liquid chromatography with mass spectrometry. Immunoassays may be used for screening, but mass spectrometry provides structural confirmation.

Does AOD-9604 have approved therapeutic uses?

No widely approved therapeutic indication exists for AOD-9604. It has been investigated in clinical studies, but regulatory approvals for general medical use are not established.

Is AOD-9604 the same as human growth hormone?

No. It is a synthetic peptide fragment modeled on part of human growth hormone, not the full hormone. It does not contain the complete sequence or receptor-binding regions of hGH.

Network